For the first time, the tools to rewrite human biology are moving from speculative fiction into regulated clinics and ...
The cancer gene MYC camouflages tumours by suppressing alarm signals that normally activate the immune system. This finding from a new study offers ...
These findings — from a blood test to improvements in drug delivery — may lead to better diagnosis and treatment of the ...
Few companies stand better poised than Beam Therapeutics to reap the first fruits of the FDA’s promised flexibility toward cell and gene therapies. | Riding a regulatory win for its base editing ...
In a Q&A for Fierce Pharma Marketing’s “Rising Stars” series, Catie Matthews suggested that marketers should embrace artificial intelligence in their own lives.
ATTR program on hold amid safety risks; HAE therapy faces tough rivals and small market. Read more analysis here.
Korro Bio, Inc. ( KRRO) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 1:30 PM EST ...
Chinese scientist He Jiankui wants to end Alzheimer’s and thinks Silicon Valley is conducting a “Nazi eugenic experiment.” ...
The Scottish Medicines Consortium (SMC) has approved the use of exagamglogene autotemcel to treat people with the chronic blood disease.